Oaktree Specialty Lending (NASDAQ:OCSL) Now Covered by Jefferies Financial Group

Share on StockTwits

Stock analysts at Jefferies Financial Group assumed coverage on shares of Oaktree Specialty Lending (NASDAQ:OCSL) in a note issued to investors on Thursday, Marketbeat.com reports. The firm set a “buy” rating and a $6.50 price target on the credit services provider’s stock. Jefferies Financial Group’s price target suggests a potential upside of 25.48% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the stock. Janney Montgomery Scott began coverage on shares of Oaktree Specialty Lending in a research report on Monday, July 29th. They set a “neutral” rating for the company. Zacks Investment Research cut shares of Oaktree Specialty Lending from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Finally, TheStreet upgraded shares of Oaktree Specialty Lending from a “c” rating to a “b” rating in a research report on Monday, August 12th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. Oaktree Specialty Lending presently has an average rating of “Hold” and a consensus target price of $6.31.

Shares of NASDAQ:OCSL opened at $5.18 on Thursday. The firm has a 50 day moving average of $5.17 and a 200-day moving average of $5.30. The stock has a market capitalization of $717.49 million, a PE ratio of 10.39, a PEG ratio of 5.06 and a beta of 0.51. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.18. Oaktree Specialty Lending has a 12 month low of $4.08 and a 12 month high of $5.75.

Oaktree Specialty Lending (NASDAQ:OCSL) last issued its earnings results on Wednesday, August 7th. The credit services provider reported $0.12 EPS for the quarter, meeting the consensus estimate of $0.12. The company had revenue of $36.67 million during the quarter, compared to analysts’ expectations of $39.57 million. Oaktree Specialty Lending had a net margin of 96.11% and a return on equity of 7.66%. On average, research analysts predict that Oaktree Specialty Lending will post 0.48 EPS for the current fiscal year.

In related news, major shareholder Leonard M. Tannenbaum sold 22,725 shares of the company’s stock in a transaction that occurred on Tuesday, September 17th. The shares were sold at an average price of $5.26, for a total transaction of $119,533.50. 0.16% of the stock is owned by corporate insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Fox Run Management L.L.C. acquired a new position in Oaktree Specialty Lending during the 2nd quarter worth approximately $58,000. Raymond James Trust N.A. acquired a new position in Oaktree Specialty Lending in the 2nd quarter valued at approximately $62,000. Almitas Capital LLC acquired a new position in Oaktree Specialty Lending in the 1st quarter valued at approximately $72,000. Quantitative Systematic Strategies LLC acquired a new position in Oaktree Specialty Lending in the 2nd quarter valued at approximately $81,000. Finally, Brown Advisory Inc. acquired a new position in Oaktree Specialty Lending in the 2nd quarter valued at approximately $108,000. Institutional investors and hedge funds own 50.00% of the company’s stock.

Oaktree Specialty Lending Company Profile

Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies.

Read More: Quiet Period Expirations

Receive News & Ratings for Oaktree Specialty Lending Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Specialty Lending and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.